Category: Regulatory/FDA

Sen. Grassley Wants An Accounting of Pharmaceutical and Medical Device Company Contributions

Outgoing NJ AG Report Recommends Further Limits to Physician-Industry Relationships

The Coalition Speaks Out on New DTC Research Analysis

FDA Hearing on the Internet and Social Media – Highlights and Commentary

Peter Pitts – Day 2 of FDA Social Media Hearing

Peter Pitts Summarizes Day 1 of FDA Social Media Hearing

Coalition and AAAA Publish Joint FDA Social Media Testimony

AAFP Defends Pharma Participation in CME

CEI Report Says FDA-DDMAC Policy Could Restrict Information for Patients